Table 1 Hospitalization for underlying diseases during the characterization period, in patients and in the general population, stratified by age. Data are given as number and percentages (in brackets) for RSV patients and percentages for the general population
From: Clinical and economic burden of respiratory syncytial virus in children aged 0–5 years in Italy
RSV patients (N = 1378) | General population | |||||||
|---|---|---|---|---|---|---|---|---|
Description | Age 0–1 year (N = 829) | Age 1–2 years (N = 406) | Age 2–5 years (N = 143) | Age 0–5 years (N = 1378) | Age 0–1 year | Age 1–2 years | Age 2–5 years | Overall 0–5 years |
Premature birth (< 37 gw) | 84 (10.1%) | 31 (7.6%) | 16 (11.2%) | 116 (8.4%) | 3.1% | 0.1% | 0% | 0.5% |
Congenital cardiopathy | 33 (4.0%) | 13 (3.2%) | 13 (9.1%) | 59 (4.3%) | 1.7% | 0.2% | 0% | 0.3% |
Chronic lung disease | 0 (0%) | NI | 0 (0%) | NI | 0% | 0% | 0% | 0% |
Cerebral palsy | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0% | 0% | 0% | 0% |
Hematological diseases | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0% | 0% | 0% | 0% |
Acute bronchiolitis due to other infectious organisms | 24 (2.9%) | 19 (4.7%) | 6 (4.2%) | 49 (3.6%) | 1.0% | 1.1% | 0% | 0.3% |